Pediatrix Medical Group Statistics
Total Valuation
MD has a market cap or net worth of $1.32 billion. The enterprise value is $1.62 billion.
| Market Cap | 1.32B |
| Enterprise Value | 1.62B |
Important Dates
The last earnings date was Tuesday, August 5, 2025, before market open.
| Earnings Date | Aug 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
MD has 85.39 million shares outstanding. The number of shares has increased by 2.21% in one year.
| Current Share Class | 85.39M |
| Shares Outstanding | 85.39M |
| Shares Change (YoY) | +2.21% |
| Shares Change (QoQ) | +0.12% |
| Owned by Insiders (%) | 1.30% |
| Owned by Institutions (%) | 88.92% |
| Float | 84.23M |
Valuation Ratios
The trailing PE ratio is 11.98 and the forward PE ratio is 8.75.
| PE Ratio | 11.98 |
| Forward PE | 8.75 |
| PS Ratio | 0.67 |
| Forward PS | 0.68 |
| PB Ratio | 1.58 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 5.83 |
| P/OCF Ratio | 5.41 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.86, with an EV/FCF ratio of 7.16.
| EV / Earnings | 14.78 |
| EV / Sales | 0.84 |
| EV / EBITDA | 6.86 |
| EV / EBIT | 7.63 |
| EV / FCF | 7.16 |
Financial Position
The company has a current ratio of 1.80, with a Debt / Equity ratio of 0.78.
| Current Ratio | 1.80 |
| Quick Ratio | 1.74 |
| Debt / Equity | 0.78 |
| Debt / EBITDA | 2.44 |
| Debt / FCF | 2.86 |
| Interest Coverage | 5.59 |
Financial Efficiency
Return on equity (ROE) is 14.27% and return on invested capital (ROIC) is 9.22%.
| Return on Equity (ROE) | 14.27% |
| Return on Assets (ROA) | 6.50% |
| Return on Invested Capital (ROIC) | 9.22% |
| Return on Capital Employed (ROCE) | 12.09% |
| Revenue Per Employee | $471,050 |
| Profits Per Employee | $26,679 |
| Employee Count | 4,120 |
| Asset Turnover | 0.95 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, MD has paid $31.70 million in taxes.
| Income Tax | 31.70M |
| Effective Tax Rate | 22.39% |
Stock Price Statistics
The stock price has increased by +53.01% in the last 52 weeks. The beta is 1.21, so MD's price volatility has been higher than the market average.
| Beta (5Y) | 1.21 |
| 52-Week Price Change | +53.01% |
| 50-Day Moving Average | 13.48 |
| 200-Day Moving Average | 13.94 |
| Relative Strength Index (RSI) | 71.99 |
| Average Volume (20 Days) | 820,015 |
Short Selling Information
The latest short interest is 1.83 million, so 2.14% of the outstanding shares have been sold short.
| Short Interest | 1.83M |
| Short Previous Month | 2.33M |
| Short % of Shares Out | 2.14% |
| Short % of Float | 2.17% |
| Short Ratio (days to cover) | 3.11 |
Income Statement
In the last 12 months, MD had revenue of $1.94 billion and earned $109.92 million in profits. Earnings per share was $1.29.
| Revenue | 1.94B |
| Gross Profit | 472.72M |
| Operating Income | 212.95M |
| Pretax Income | -267.92M |
| Net Income | 109.92M |
| EBITDA | 236.73M |
| EBIT | 212.95M |
| Earnings Per Share (EPS) | $1.29 |
Balance Sheet
The company has $348.33 million in cash and $649.56 million in debt, giving a net cash position of -$301.23 million or -$3.53 per share.
| Cash & Cash Equivalents | 348.33M |
| Total Debt | 649.56M |
| Net Cash | -301.23M |
| Net Cash Per Share | -$3.53 |
| Equity (Book Value) | 833.75M |
| Book Value Per Share | 9.79 |
| Working Capital | 272.01M |
Cash Flow
In the last 12 months, operating cash flow was $244.55 million and capital expenditures -$17.56 million, giving a free cash flow of $226.99 million.
| Operating Cash Flow | 244.55M |
| Capital Expenditures | -17.56M |
| Free Cash Flow | 226.99M |
| FCF Per Share | $2.66 |
Margins
Gross margin is 24.36%, with operating and profit margins of 10.97% and 5.66%.
| Gross Margin | 24.36% |
| Operating Margin | 10.97% |
| Pretax Margin | 7.30% |
| Profit Margin | 5.66% |
| EBITDA Margin | 12.20% |
| EBIT Margin | 10.97% |
| FCF Margin | 11.70% |
Dividends & Yields
MD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.21% |
| Shareholder Yield | -2.21% |
| Earnings Yield | 8.31% |
| FCF Yield | 17.15% |
Analyst Forecast
The average price target for MD is $16.67, which is 7.55% higher than the current price. The consensus rating is "Buy".
| Price Target | $16.67 |
| Price Target Difference | 7.55% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 2.68% |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 20, 2013. It was a forward split with a ratio of 2:1.
| Last Split Date | Dec 20, 2013 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
MD has an Altman Z-Score of 1.8 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.8 |
| Piotroski F-Score | 8 |